Odyssey Health (ODYY) Share-based Compensation (2019 - 2026)
Odyssey Health (ODYY) reported Share-based Compensation of -$1750.0 for Q2 2026, down 114.85% year-over-year from $11781.0 in Q2 2025, and down 200.0% sequentially from $1750.0 in Q4 2025.
Odyssey Health (ODYY) Share-based Compensation (2019 - 2026) Analysis & Trends
Odyssey Health has disclosed Share-based Compensation across 8 years of filings, most recently posting -$1750.0 for Q2 2026.
- Quarterly Share-based Compensation fell 114.85% year-over-year to -$1750.0 in Q2 2026, while the trailing twelve-month figure through Jan 2026 was $13531.0 (up 104.15% YoY) and the FY2025 annual result came in at $108399.0, down 81.24% from the prior year.
- Share-based Compensation fell to -$1750.0 in Q2 2026, from $1750.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.0 million in Q2 2022 and bottomed at -$473797.0 in Q3 2024.
- The 5-year median for Share-based Compensation is $96618.0 (2025), against an average of $386248.1.
- Year-over-year, Share-based Compensation soared 357.64% in 2022 and slumped 220.62% in 2024.
- Odyssey Health's Share-based Compensation stood at $1.2 million in 2022, then slumped by 99.85% to $1750.0 in 2023, then sank by 27174.11% to -$473797.0 in 2024, then surged by 100.37% to $1750.0 in 2025, then sank by 200.0% to -$1750.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered -$1750.0, $1750.0, and $11781.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Odyssey Health | - | - | - | -1,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1,750.00 |
| Apr 30, 2026 | -1,750.00 |
| Oct 31, 2025 | 1,750.00 |
| Oct 31, 2025 | 1,750.00 |
| Apr 30, 2025 | 11,781.00 |
| Apr 30, 2025 | 11,781.00 |
| Jan 31, 2025 | 96,618.00 |
| Jan 31, 2025 | 96,618.00 |
| Jul 31, 2024 | -473,797.00 |
| Jul 31, 2024 | -473,797.00 |
| Apr 30, 2024 | 51,483.00 |
| Apr 30, 2024 | 51,483.00 |
| Jan 31, 2024 | 998,369.00 |
| Jan 31, 2024 | 998,369.00 |
| Oct 31, 2023 | 1,750.00 |
| Oct 31, 2023 | 1,750.00 |
| Jul 31, 2023 | 392,811.00 |
| Jul 31, 2023 | 392,811.00 |
| Apr 30, 2023 | 598,964.00 |
| Apr 30, 2023 | 598,964.00 |